Joaquim J Ferreira

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Werner Poewe, Andrew Lees, Olivier Rascol, 2016, The Lancet Neurology.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Enrico Amico, Philippe Allain, Mark Mühlau, 2017, The Lancet. Neurology.

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY

Alexander Münchau, Caroline Hallam, Andrea Ciarmiello, 2011, PLoS currents.

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.

Angelo Antonini, Rita G Nunes, Raquel Bouça, 2017, Journal of Parkinson's disease.

“Gunslinger’s gait”: a new cause of unilaterally reduced arm swing

Angelo Antonini, Bastiaan R Bloem, B. Bloem, 2015, British Medical Journal.

Skin cancer and Parkinson's disease

Cristina Sampaio, Tiago Mestre, Olivier Rascol, 2010, Movement disorders : official journal of the Movement Disorder Society.

Participatory design in Parkinson's research with focus on the symptomatic domains to be measured.

Walter Maetzler, Frank Larsen, Holm Graessner, 2015, Journal of Parkinson's disease.

Clinical Parameters and Tools for Home-Based Assessment of Parkinson's Disease: Results from a Delphi study.

Ahmed Al-Jawad, Walter Maetzler, Frank Larsen, 2015, Journal of Parkinson's disease.